These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17089002)

  • 1. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
    Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
    Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
    Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
    Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
    Coyle AT; Kinsella BT
    Biochem Pharmacol; 2006 Apr; 71(9):1308-23. PubMed ID: 16499875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
    Komatsu Y; Ito I; Wayama M; Fujimura A; Akaogi K; Machida H; Nakajima Y; Kuroda T; Ohmori K; Murayama A; Kimura K; Yanagisawa J
    Biochem Biophys Res Commun; 2008 May; 370(1):145-8. PubMed ID: 18355447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone and 9cis,11trans,13trans-conjugated linolenic acid: comparison of their antiproliferative and apoptosis-inducing effects on different colon cancer cell lines.
    Yasui Y; Hosokawa M; Kohno H; Tanaka T; Miyashita K
    Chemotherapy; 2006; 52(5):220-5. PubMed ID: 16899971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation.
    Nagasawa E; Abe Y; Nishimura J; Yanase T; Nawata H; Muta K
    Exp Hematol; 2005 Aug; 33(8):857-64. PubMed ID: 16038777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression.
    Gijsbers L; Man HY; Kloet SK; de Haan LH; Keijer J; Rietjens IM; van der Burg B; Aarts JM
    Anal Biochem; 2011 Jul; 414(1):77-83. PubMed ID: 21354099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells.
    Tsukahara T; Haniu H
    Biochem Biophys Res Commun; 2012 Aug; 424(3):524-9. PubMed ID: 22771328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
    Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS
    Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
    Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC
    Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
    Au-Yeung KK; Liu PL; Chan C; Wu WY; Lee SS; Ko JK
    Cancer Invest; 2008 Aug; 26(7):708-17. PubMed ID: 18608213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a truncated alternative splicing variant of human PPARgamma1 that exhibits dominant negative activity.
    Kim HJ; Woo IS; Kang ES; Eun SY; Kim HJ; Lee JH; Chang KC; Kim JH; Seo HG
    Biochem Biophys Res Commun; 2006 Sep; 347(3):698-706. PubMed ID: 16842753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for differential effects of glucose and cycloheximide on mRNA levels of peroxisome proliferator-activated receptor- (PPAR-) machinery members: Superinduction of PPAR-gamma1 and -gamma2 mRNAs.
    Rypka M; Veselý J
    Acta Biochim Pol; 2010; 57(2):209-15. PubMed ID: 20563322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment.
    Bouancheau D; Buecher B; Jarry A; Simon B; Masson D; Cassagnau E; Hamelin R; Laboisse CL; Bézieau S; Denis MG
    Cancer Lett; 2005 Jun; 224(1):111-6. PubMed ID: 15911106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.
    Ulrich S; Wächtershäuser A; Loitsch S; von Knethen A; Brüne B; Stein J
    Exp Cell Res; 2005 Oct; 310(1):196-204. PubMed ID: 16112107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines.
    Park JW; Zarnegar R; Kanauchi H; Wong MG; Hyun WC; Ginzinger DG; Lobo M; Cotter P; Duh QY; Clark OH
    Thyroid; 2005 Mar; 15(3):222-31. PubMed ID: 15785241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability.
    Bruedigam C; Koedam M; Chiba H; Eijken M; van Leeuwen JP
    FEBS Lett; 2008 May; 582(11):1618-24. PubMed ID: 18435931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PPARgamma is reduced by medium supplementation with L-glutamine in human colorectal Caco-2 cells.
    Fiatte C; Huin C; Collet P; Plénat F; Dauça M; Schohn H
    Int J Mol Med; 2008 Dec; 22(6):825-32. PubMed ID: 19020782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.